Online
|
|
BSE Announcements on Novartis India
Posted by :
MMB Messenger
DSP Merrill Lynch Ltd ("Manager to the Offer") for & on behalf of Novartis AG ("Acquirer") has issued this Supplemental Public Announcement to the shareholders of Novartis India Ltd ("Target Company"), which is in continuation of and should be read in conjunction with the Public Announcement (PA) dated March 27, 2009, the Letter of Offer dated May 14, 2009 and the corrigendum to the shareholders of the Target Company dated May 15, 2009, pursuant to Regulation 11(1) of, and in compliance with, the Securities and Exchange Board of India (the "SEBI") (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and subsequent amendments thereto (the "Regulations")
Capitalized terms used in this Supplemental Public Announcement but not defined shall have the same meaning as assigned in the PA.
The shareholders of the Target Company may note the following:
1. Upward Revision of the price of the Offer (the "Offer Price") to the shareholders of the Target as follows:
Offer Price (per fully paid-up equity share of Target)
Original Offer Price - Rs 351 per Share (Rupees Three Hundred and Fifty One)
Revised Offer Price - Rs 450 per Share (Rupees Four Hundred and Fifty)
2. Pursuant to the upward revision in the Offer Price, the maximum consideration required to meet the obligation of Offer assuming 100% acceptance is Rs 5,609,119,500/- (Rupees Five Billion Six Hundred and Nine Million One Hundred and Nineteen Thousand and Five Hundred only) ("Revised Maximum Consideration").
3. The Offer closes on June 8, 2009.
The other terms and conditions of the Offer remain unchanged....
BSE Announcements on Novartis India
Posted by :
prasadms
From novartis web site
Novartis increases its offer price on Novartis India Ltd.
This release is neither an offer to purchase nor a solicitation of an offer to sell shares of Novartis India Ltd.
Basel, Switzerland, May 28, 2009 - Novartis announced today an increase in the offer price for Novartis India Ltd. to Rs 450 per share, from Rs 351 initially proposed.
The revised offer represents a premium of 63% to the closing share price of Rs 275.6 of Novartis India Ltd. on March 24, which was the last trading day before announcement of the offer.
This proposal represents Novartis` only and final price revision to this offer, as May 28 is the last day on which the price can be revised.
...
BSE Announcements on Novartis India
Posted by :
phirozabanYou are right. The imbeciles on behalf of those who want to acquire Share go on phoning from phone No 2240306015 enquiring why the shareholders have not tendered their shares in the ...
BSE Announcements on Novartis India
Posted by : phirozabanThe promoters hold only 50% Over 21.30 % is held by institutions out of which LIC holds 5.67 %. They are not going to fall for the Open Offer. The Open Offer is destined to be a flop show....
BSE Announcements on Novartis India
Posted by : stkstudentThanks for the tip. However today I exited the scrip @ 410. After observing the stock performance, shall re-enter when the price is low enough. ...
BSE Announcements on Novartis India
Posted by : stkstudentThanks for the tip. However today I exited the scrip @ 410. After observing the stock performance, shall re-enter when the price is low enough. ...
BSE Announcements on Novartis India
Posted by : phirozabanSell in themarket at around Rs. 440/ in first week of June. If the Offer fails,buy the shares back at around Rs. 340/...
BSE Announcements on Novartis India
Posted by : stkstudentNow the offer price from 20/5 to 8/6/09 seems at the same old price, under the circumstances can one expect a higher price than the CMP ? or would the buying be done at prevailing market prices during the period 20/5 to 8/6/09 ? In that case the market price may go up much higher, what should be the strategy henceforth ?...
BSE Announcements on Novartis India
Posted by : MMB Messenger
DSP Merrill Lynch Ltd ("Manager to the Offer") for & on behalf of Novartis AG ("Acquirer") has issued this Corrigendum to Public Announcement to the shareholders of Novartis India Ltd ("Target Company"), which is in continuation of and should be read in conjunction with the Public Announcement (PA) dated March 27, 2009, pursuant to Regulation 11(1) of, and in compliance with, the Securities and Exchange Board of India ("SEBI") (Substantial
Acquisition of Shares and Takeovers) Regulations, 1997 and subsequent amendments thereto (the "Regulations")
Capitalized terms used in this Corrigendum unless otherwise defined shall have the same meaning as assigned to them in the PA.
The shareholders of the Target may note the following:
Time schedule for major activities for the Offer under Para 9 of the PA should be read as:
Date of Opening of the Offer - May 20, 2009
Date of Closing of the Offer - June 08, 2009...
BSE Announcements on Novartis India
Posted by : MMB MessengerNovartis India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 10, 2009 to July 17, 2009 (both days inclusive) for the purpose of payment of dividend & 61st Annual General Meeting (AGM) of the Company....
BSE Announcements on Novartis India
Posted by :
punit1255Thanks for the good information with source, putting fulstop to lot of unwanted speculation....
BSE Announcements on Novartis India
Posted by : MMB MessengerNovartis India Ltd has informed BSE regarding a Media Release dated May 08, 2009 titled "Novartis India recommends dividend of 200% (Rs 10 per share) for 2008-09"...
BSE Announcements on Novartis India
Posted by : MMB MessengerNovartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2009, inter alia, has recommended Dividend of 200% (Rs 10/- per equity share of Rs 5 each) for the year ended March 31, 2009....
BSE Announcements on Novartis India
Posted by : MMB MessengerNovartis India Ltd has informed BSE about the Unaudited Financial results for the quarter ended & Audited Financial Results for year ended March 31, 2009....
BSE Announcements on Novartis India
Posted by : prasadms
Novartis` open offer hangs in balance
Accoridng to an article in economic times.
When contacted, a Novartis International AG spokesperson told ET that the company would not revise the open offer price.
“There has been a lot of speculation since the offer was announced, pushing the price up. The offer price was at a significant premium to the last traded price of the stock before it was announced,” he said. He also added that Novartis would touch base with the institutional investors of Novartis India shortly.
...
